Location History:
- Bath, GB (2017 - 2022)
- Abingdon, GB (2020 - 2023)
Company Filing History:
4 out of 6 
3 out of 4 
2 out of 42 
Years Active: 2017-2025
Title: The Innovative Contributions of Jonathan David Hargrave
Introduction
Jonathan David Hargrave is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of respiratory disease treatment through his innovative research and development. With a total of 9 patents to his name, Hargrave's work focuses on the modulation of TMEM16A, a calcium-activated chloride channel.
Latest Patents
Hargrave's latest patents include groundbreaking compounds designed for treating respiratory diseases. One of his notable inventions is titled "Modulators of TMEM16A for treating respiratory disease." This patent describes compounds of general formula (I), wherein specific variables are defined to be useful for treating respiratory diseases and other conditions modulated by TMEM16A. Another significant patent involves compounds that act as positive modulators of TMEM16A, which are particularly beneficial for conditions affected by this channel.
Career Highlights
Throughout his career, Jonathan David Hargrave has worked with various companies, including Enterprise Therapeutics Limited and Tmem16a Limited. His work in these organizations has been pivotal in advancing the understanding and treatment of respiratory diseases.
Collaborations
Hargrave has collaborated with notable individuals in his field, including Duncan Alexander Hay and Thomas Beauregard Schofield. These partnerships have contributed to the success of his research and the development of innovative treatments.
Conclusion
Jonathan David Hargrave's contributions to the field of respiratory disease treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical science and patient care.